Musculoskeletal

MedTech News for Cardiovascular Systems, Koneksa, Medcura, Abbott, Enovis, Bausch + Lomb, AcuFocus

Notizia - Recent Pharma, Healthcare and Biotech Happenings

First Patient Enrolled in Kaizen Clinical Study in Japan; Koneksa’s At-Home Mobile Spirometry Clinical Trial; Medcura’s LifeGel™ Absorbable Surgical Hemostat; FDA Clearance to Abbott’s NAVITOR; Enovis’s DynaClip Delta™ and DynaClip Quattro™ bone staples; Bausch + Lomb Acquired AcuFocus

First Patient Enrolled in Kaizen Clinical Study in Japan On January 11, 2023, Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients suffering from peripheral and coronary artery disease, announced the initiation of the KAIZEN clinical study of its Diamondback 360 Peripheral Orbital Atherectomy System (OAS) with the enrolment of the first patient in the trial in Japan. KAIZEN is a prospective, single-arm, multi-center study aimed at evaluating the safety and efficacy of the company’s Diamondback 360 Peripheral OAS in the treatment of de novo symptomatic calcified ...

Explore More...

medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign

Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies’s Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic

Bone Metastasis Market: A Debilitating Consequence for Many Tumors

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune

Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical

Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zimmer-Canary’s Smart Knee Implant; COVID-19 impact on Solid Organ Transplants

leading-companies-in-the-musculoskeletal-disorders-market

Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics Market

key-companies-in-the-bone-cancer-treatment-market-

Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth

recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

osteoporosis-symptoms-risk-factors-diagnosis-and-treatment-options

Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing

Chronic Pain Market Landscape | Chronic Pain Pipeline | Osteoarthritis

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Musculoskeletal

First Patient Enrolled in Kaizen Clinical Study in Japan; Koneksa’s At-Home Mobile Spirometry Clinical Trial; Medcura’s LifeGel™ Absorbable Surgical Hemostat; FDA Clearance to Abbott’s NAVITOR; Enovis’s DynaClip Delta™ and DynaClip Quattro™ bone staples; Bausch + Lomb Acquired AcuFocus

Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies’s Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic

Bone Metastasis Market: A Debilitating Consequence for Many Tumors

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zimmer-Canary’s Smart Knee Implant; COVID-19 impact on Solid Organ Transplants

Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics Market

Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

More Views & Analysis

How Is Osteoporosis Impacting The Quality Of Life?

MedTech Industry Roars Back as FDA Approvals Soar

A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers

Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing

Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape

How Robots Are Introducing A New Dimension To Healthcare Service Delivery

A Need for Curative Treatment Expected to Attract the Pharma Players in the Hallux Valgus Market Landscape

Parkinson’s Disease: How close are we to a cure?

Subscribe to our Updates

Daily

Weekly

Monthly